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ABSTRACT: The effi cacy of an autogenous vaccine consisting of a whole cell suspension of formalin killed bacteria in 
sterile buffered saline against Staphylococcus aureus infections was determined, using a well-established rabbit skin 
infection model. Thirteen 8 wk old rabbits were vaccinated twice subcutaneously with a 2 wk interval while 10 rabbits 
were injected twice with formalised PBS (sterile phosphate buffered saline). Two weeks after the last injection, 10 
vaccinated and all PBS-injected rabbits were inoculated intradermally with 108 cfu of a S. aureus strain (KH 171)which 
had been shown to be highly virulent for rabbits. Three vaccinated animals served as negative controls and were 
intradermally injected with sterile buffered saline. All rabbits were examined daily for the development of skin lesions 
until 14 d after the experimental infection when all rabbits were euthanised. All animals experimentally infected with 
S. aureus developed skin abscesses within 24 h post-inoculation, but in the vaccinated group the maximum abscess 
diameter was signifi cantly lower than in the non-vaccinated group (P=0.048). This difference between autovaccinated 
and non-vaccinated groups increased over time (P<0.001). These results indicate that vaccination with an inactivated 
whole cell bacterin may be useful for control of staphylococcosis in rabbits but does not prevent abscess formation in 
animals inoculated with a high dose of a highly virulent S. aureus strain.
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INTRODUCTION
Staphylococcus aureus causes many problems in rabbits such as subcutaneous abscesses, mastitis, 
pododermatitis, and can occasionally evolve to septicaemia (Corpa et al., 2009). It is commonly accepted 
that these symptoms occur after infection of a wound with S. aureus. At rabbit fl ock level, two types 
of infection can be distinguished. In the fi rst type, caused by low virulence (LV) strains, only a few 
number of animals develop symptoms and the economic importance therefore remains low. In the case 
of the second type of infection, caused by high virulence (HV) strains, the disease spreads throughout 
the entire fl ock affecting general health, growth and reproduction parameters. This leads to chronically 
poor production results and increased slaughterhouse condemnations. The use of antibiotics in feed or 
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drinking water or topically applied does not offer an effective therapy (Okerman et al., 1984; Hermans 
et al., 2003) and often all animals have to be culled due to the high economic losses. In rabbit farming, 
vaccination would thus be a very valuable alternative to control the disease. In general, attempts to 
develop a vaccine against S. aureus encounter many difficulties (Lee, 1996; Projan et al., 2006). Vaccines 
that have been tested in animals include whole-cell vaccines based on live and killed S. aureus bacteria, 
capsular vaccines and protein vaccines such as alpha-toxoid vaccine. Rabbits have been used as a model 
for testing the efficacy of bovine S. aureus vaccines. In a rabbit mastitis model, some degree of protection 
against challenge, toxin spread and subsequent death was found after vaccination with purified alpha- and 
beta-toxins from bovine S. aureus strains, but not against abscess formation (Adlam et al., 1977). Bovine 
mastitis vaccines, based on whole bacterial cells, crude toxoid (α- and β-haemolysins) or combinations 
of both induced variable protection in a rabbit skin infection model depending on the strain combination 
used, the amount of toxoid included in the vaccine and the number of vaccine injections (Cameron et al., 
1979). Hinton (1977) reported that therapeutic administration of an autogenous S. aureus vaccine resulted 
in a temporary clinical improvement of conjunctivitis in rabbits. To our knowledge, there are no other 
reports on the efficacy of vaccines specifically designed for use in rabbits. 
In the field, autogenous vaccines are sometimes used in an attempt to control the problems with HV 
S. aureus in rabbits at flock level, with variable success rates. Results of vaccination in the field may 
be influenced by several interfering factors including concurrent diseases and management practices. 
Therefore, the aim of this study was to evaluate the effect of an autogenous bacterin in a well-standardised 
rabbit skin infection model (Meulemans et al., 2007). 
MATERIAL AND METHODS
Experimental animals
The animal experiments were carried out after approval from the ethical committee of the Faculty 
of Veterinary Medicine of Ghent University. Twenty-three 8 wk albino hybrid rabbits (ILVO, Melle, 
Belgium), weighing 2.0-2.5 kg and from either sex were kept individually in polyethylene benches and 
received food and water ad libitum. Before the onset of the experiment, rectal temperature was measured 
and the following body sites were sampled for bacteriological examination as described by Hermans et 
al. (1999): the nares, auditory canal, interdigital skin, medial skin of the right foreleg, axillar and inguinal 
skin region, skin around the nipples, perineum and vagina or preputium. The samples were screened for 
the presence of HV S. aureus strains. 
Preparation of the challenge inoculum
In all experiments, the highly virulent (HV) S. aureus isolate KH 171 (Hermans et al., 1999) was used. 
This strain belongs to the biotype mixed CV-C, is sensitive to the phages of phage group II (3A, 3C, 55 
and 71) displays spa type t645, MLST type ST121 and therefore belongs to the widely disseminated 
clone that has previously been described as highly virulent (Vancraeynest et al., 2006; 2007). Originally, 
the strain was isolated in a Belgian rabbitry experiencing severe problems with mastitis, pododermatitis, 
pustular dermatitis and subcutaneous abscesses. Its virulence has been demonstrated in a rabbit intranasal 
colonisation experiment (Hermans et al., 2000) and in a rabbit skin infection model (Meulemans et al., 
2007).
The isolate was grown for 24 h at 37°C on Columbia agar (Gibco, Paisley, Scotland) containing 5% ovine 
blood (blood agar) in a 5% CO2-enriched environment. After checking the strain for purity, 10 colonies 
were transferred into brain heart infusion (BHI) (Oxoid, Basingstoke, England) broth for 24 h at 37°C 
whilst shaking. The number of colony forming units (cfu) was determined by inoculation of 10-fold 
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dilutions on blood agar and the suspension was stored overnight (O/N) at 4°C in phosphate buffered saline 
(PBS). Prior to the experiment, the suspension was centrifuged at 1500 rpm and the pellet adjusted to an 
appropriate concentration of 109 cfu/mL PBS (108 cfu/0.1 mL PBS).
Preparation of the autogenous vaccine
S. aureus strain KH 171 was grown for 24 h at 37°C on blood agar in a 5% CO2-enriched environment. 
After checking the purity of the strain, 5 colonies were transferred into 200 mL of sterile Columbia broth 
(Difco, Becton Dickinson and Company, Sparks, USA) and incubated for 24 h at 37°C whilst shaking. 
After checking its purity and confirmation of the identity of the strain, 1 mL of formaldehyde 36% (VWR 
International, Fontenay-sous-Bois, France) was added and the broth was incubated O/N at 37°C.
The following day, the sterility of the suspension was checked by inoculation onto a blood agar plate. The 
broth was then centrifuged at 5000 rpm for 30 min at room temperature. The supernatant was discarded 
and the pellet was resuspended in 100 mL of sterile PBS with 0.5% formaldehyde and the concentration of 
the formalised staphylococcal suspension was assessed using a McFarland nephelometer. The suspension 
was again incubated at 37°C O/N and after dispensing it into sterile glass vaccine bottles, sterility was 
confirmed by direct inoculation of a loopful of the vaccine suspension onto blood, Sabouraud (Oxoid, 
Basingstoke, England) and PAM agar (Difco, Becton Dickinson and Company, Sparks, USA) and 
incubating for 7 d at 37°C. Additionally, 1 mL of the formalised suspension was added to 10 mL of brain-
heart infusion (BHI), thioglycollate, Sabouraud (Oxoid, Basingstoke, England) and PPLO (Difco, Becton 
Dickinson and Company, Sparks, USA) broth at 37°C. Inoculated broths were examined daily visually for 
2 wk for the absence of bacterial growth and their sterility was confirmed by inoculation on the previously 
mentioned agars and incubating for 7 d at 37°C.
Experimental design
The rabbits were randomly allocated to 2 groups of 10 animals (group A=vaccinated; group B=non-
vaccinated) while 3 animals were kept as negative controls. The rabbits of group A and the 3 negative 
control animals were vaccinated twice subcutaneously with 0.5 mL of the bacterin with an interval of 2 wk. 
At the same time, the rabbits of group B were injected twice with 0.5 mL of formalised PBS. Two weeks 
after the second injection, rabbits of group A and B were anaesthetised with isoflurane (IsoFlo®, Abbott 
Laboratories Ltd., Queensborough, England) by mask induction. As previously described by Meulemans 
et al. (2007), the fur of the right flank was shaved with electric clippers (Contura, Wella, Germany) and 
disinfected thoroughly with 70% ethanol (Disinfectol®, Chem-Lab NV, Zedelgem, Belgium) for 5 min. 
After evaporation of the ethanol, a tattoo pin (letter “O”; width×length=5×7mm) was pressed into the 
skin, producing a 0.5 mm deep “O”-shaped dermal skin lesion. The lesion was then inoculated with 108 
cfu of the KH171 S. aureus strain in 0.1 mL PBS. In the negative control animals, the same procedure 
was followed but the skin lesions were sham inoculated with 0.1 mL sterile PBS. After the inoculum was 
air-dried, the rabbits were allowed to recover from the anaesthesia. 
Rabbits were inspected daily for the development of macroscopic skin lesions and their rectal temperatures 
were measured. Skin lesions were measured by means of a vernier calliper. The person measuring and 
scoring the lesions was unaware of the treatment assignment (blinding). At 14 d post-inoculation (pi) the 
animals of groups A and B were euthanised and swab samples of the nares and flanks (abscesses) were 
collected for bacteriological analysis, as were skin biopsies for histopathological examination. All animals 




All samples were inoculated onto blood agar. Samples of the nares and perineum were additionally cultured 
on modified Baird-Parker agar (Devriese, 1981). After 24 h incubation at 37°C, S. aureus colonies were 
identified and classified into biotypes as described by Devriese (1984). Phage typing of the isolated S. 
aureus colonies was performed at the Scientific Institute of Public Health (Brussels, Belgium) using 
bacteriophages of the international typing set for human S. aureus strains according to Parker (1962).
Histopathological examination 
Representative skin biopsies of the right flank with underlying muscle and biopsies of other encountered 
lesions were fixed in 10% buffered formalin, paraffin embedded and cut into 5 µm slices. After 
conventional haematoxylin-eosin (HE) staining, tissue sections were evaluated using light microscopy. 
Histopathological lesions were classified according to the following parameters: crust formation, 
epidermal hyperplasia, degree of necrosis and type of inflammation in different dermal parts (superficial, 
mid and deep dermis) and the subcutis.
Statistical analysis
The LOCF (last observation carried forward) procedure was used for animals euthanised before the 
end of the study period, assigning the value of the last observation for the remaining time points. Two 
different parameters were compared statistically. Firstly, the maximum abscess diameter reached after 
inoculation was compared for the challenged animals from both groups. This parameter is a reflection of 
the severity of the inflammatory reaction and will have an impact on the possibility of healing (Cotran 
et al., 1999). This statistical comparison was performed by means of a one-sided Wilcoxon rank sum 
test. Secondly, in order to evaluate the development of the abscess diameter over time, a mixed model 
analysis was performed with animal as random effect, and time, autovaccine and their interaction as fixed 
categorical effects. Within the mixed model, control and vaccinated groups were compared per day using 
Bonferroni’s multiple comparisons technique with a significance level of 0.0036 (i.e. 0.05/14, as the 
abscess measurements on different days are not independent from each other).
RESULTS
Clinical examination
Four rabbits showed clinical signs of pain and loss of appetite and were therefore euthanised at 8 d pi. 
The rest of the animals remained alert and showed normal appetite and grooming activities throughout 
the whole experiment. Rectal temperatures stayed within the normal range (Harcourt-Brown, 2002) and 
varied between 37.8°C and 39.6°C. 
Macroscopic evaluation of lesions
The 3 animals from the unchallenged vaccinated group (negative controls) did not develop any lesions. 
The animals from both other groups developed an abscess on the right flank within 24 h pi, with a diameter 
varying from 8 to 40 mm. The evolution of the mean abscess diameters in both the autovaccinated (group 
A) and non-vaccinated (group B) rabbits during the 2 wk observation period after challenge with the HV 
S. aureus strain is represented in Figure 1. 
At 8 d pi, 1 rabbit from group A and 3 rabbits from group B showing clinical signs of pain and loss of 
appetite, were euthanised for ethical reasons. Those animals had abscesses with a minimum diameter of 
at least 55 mm for 3 subsequent days. 
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In the challenged and vaccinated group A, all 
animals developed abscesses on the right flank of 
at least 20 mm within the 1st wk of the study, with 
diameters ranging from 20-65 mm. From then 
onwards, all abscesses of the 9 surviving animals 
started to regress. The maximal abscess diameter 
was reached within the first 48 h pi for 2 out of 10 
animals. The rest of the group reached its maximal 
abscess size 5 to 7 d after infection. At the end of 
the experiment, lesion diameters varied between 
4 and 38 mm, with 6 of them measuring less than 
20 mm. 
In the non-vaccinated group B, all animals 
developed abscesses of at least 18 mm. Eight of 
them reached their maximum diameter at 5 to 8 d 
after inoculation with diameters ranging from 18-
90 mm. In one rabbit, maximal nodule size was 
noted at the last day of the experiment. Another rabbit developed an abscess of 30 mm after 24 h that 
started to regress after 1 d to enlarge again to 28 mm at 4 d. After a second regression to 14 mm at 12 d, it 
enlarged again to 24 mm on the last day of the experiment. At the end of the experiment lesion diameters 
from 9 to 77 mm were noted in group B. 
In 6 out of 10 animals from group A and 7 out of 10 animals from group B, a small abscess (1-3 mm) 
appeared on the lower and/or upper lips from 7 or 8 d pi onwards. 
Bacteriological examination
From the body samples taken before the experiment was started, no HV S. aureus was isolated.
At the end of the experiment, 3 rabbits each in both groups A and B were positive for HV S. aureus in 
the nose. In the vaccinated group A, 9 rabbits were positive on the right flank compared to 10 rabbits in 
group B. No changes were noted in the biotype or phage type of the isolates obtained at the end of the 
experiment, compared to the inoculated strain. 
Abscess diameter
Firstly, the maximum abscess diameter reached after inoculation was compared for the animals of both 
groups. The autovaccinated animals had a significantly (P=0.0477) lower maximum abscess diameter 
than the control animals (Figure 1). 
Secondly, the development of the abscess diameter during the course of the experiment was evaluated. 
The abscess diameter changed significantly over time (P<0.001) and in a different way in the 2  groups 
(significant interaction between group and time; P<0.001): until 5 d, the differences between the 2 groups 
were small, but thereafter the differences increased mainly due to the fact that the abscess diameter 
slightly decreased in the autovaccinated group whereas it continued to increase in the control group. The 
largest difference in abscess diameter between the challenged vaccinated and non-vaccinated group was 
found on the final day of the experiment, where it just failed to be declared statistically significant as the 
P value was slightly higher than 0.0036 (P=0.005). Globally, there was only a tendency towards a smaller 




















Figure 1: Evolution of the mean abscess diameters 
(in mm) in the autovaccinated group A (Δ) and the 
non-vaccinated group B (×) during two weeks after 




The skin of the 4 rabbits euthanised at 8 d 
showed an extensive area of necrosis in the mid 
to deep dermis with a massive infiltration of 
degranulating polymorphonuclear leukocytes 
(PMN) and some monocytes. There was also 
evidence of collagenolysis and myolysis. The 
histopathological changes in the skin of a non-
vaccinated rabbit at 8 d are presented in Figure 2.
In group A, skin biopsies of the animals euthanised 
at the end of the experiment showed moderate to 
marked epidermal hyperplasia, mild subepidermal 
oedema with occasional transmigration of PMN 
and mild to moderate superficial suppurative 
perivasculitis. In the mid to deep dermis there 
was evidence of fibrosis, follicular atrophy and 
mild to moderate multifocal perivasculitis with 
predominant infiltration of mononuclear cells 
(monocytes, lymphocytes and plasma cells) and 
some PMN. In the muscular layer, there was focal 
infiltration of monocytes and lymphocytes. These 
Figure 2: Histopathological changes (haematoxylin-
eosin stained sections, light microscope, 25×) in the 
skin biopsy of a non-vaccinated rabbit euthanised 
at 8 d post-inoculation, showing an extensive area 
of dermal necrosis with a massive infiltration of 
degranulating polymorphonuclear leukocytes and 
some monocytes.
Figure 3: Histopathological changes (haematoxylin-
eosin stained sections, light microscope, 50×) in the 
skin biopsy of an autovaccinated rabbit (group A) at 
2 wk after infection, showing epidermal hyperplasia, 
mild subepidermal oedema and a mild to moderate 
superficial suppurative perivasculitis. In the mid 
to deep dermis there was evidence of fibrosis, 
follicular atrophy and mild to moderate multifocal 
perivasculitis with predominant infiltration of 
mononuclear cells and some polymorphonuclear 
leukocytes.
Figure 4: Histopathological changes (haematoxylin-
eosin stained sections, light microscope, 50×) in the 
skin biopsy of a non-vaccinated rabbit (group B) 
2 wk after infection, showing moderate to marked 
epidermal hyperplasia with intercellular oedema 
and transmigration of PMN. The dermis showed 
oedema and a moderate perivasculitis with marked 
infiltration of polymorphonuclear leukocytes and 
some mononuclear cells. 
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histological findings are presented in Figure 3. One animal showed a well-demarcated dermal infiltration 
of necrotic PMN surrounded by proliferating fibroblasts and some multinuclear giant cells. 
All animals in group B showed moderate to marked epidermal hyperplasia with intercellular oedema 
and transmigration of PMN. In 2 cases there was epidermal necrosis and crust formation. The dermis 
showed oedema and a moderate mid to deep perivasculitis with marked infiltration of PMN and some 
mononuclear cells. The histopathological changes in the skin of a non-vaccinated animal at the end of the 
experiment are shown in Figure 4.
No pathological changes were found in the internal organs of the necropsied rabbits. 
DISCUSSION
Although the administration of autogenous bacterin had a significant effect on the maximum abscess 
diameter in rabbits inoculated with a high dose of a highly virulent S. aureus strain, it was not able to 
prevent abscess formation or the spread of the bacteria towards other body sites, such as the nose and lips. 
Such high inoculation doses trigger an acute inflammatory reaction with the formation of large abscesses 
filled with pus. Once this stage is reached, the retraction of the abscess takes a considerable amount of 
time. This is reflected in the histological findings, where a marked dermal fibrosis was seen at the end of 
the experiment. It is however very unlikely that a naturally occurring wound under field conditions would 
be infected with such a high number of staphylococcal bacteria (108 cfu). Repeating the experiment with 
a lower inoculation dose would probably lead to better efficacy of the autovaccine. In literature, skin 
infection studies using doses of 106 cfu S. aureus bacteria have been reported (Marples and Kligman, 
1975; Kraft et al., 1986). Preliminary (unpublished) studies however have demonstrated that it is very 
difficult to obtain standardised results with lower inoculation doses. Inoculation of rabbit skin with 106 
cfu S. aureus resulted in abscesses with variable lesion sizes that disappeared within 1 wk in some of the 
animals. 
When comparing the abscess size in both groups over time: until 5 d pi, the differences between groups 
were small. From then on, the abscess diameter slightly decreased in the autovaccinated group compared to 
the non-vaccinated group, where it continued increasing. These findings suggest that in the autovaccinated 
animals the resolution time of the abscess is reduced. The largest difference between both groups was 
found at the final day of the experiment, suggesting a positive ongoing effect in the autovaccinated 
animals. It may therefore be useful to perform trials with longer observation periods, as it is possible 
that the diameter in vaccinated animals will continue to decrease and healing of the abscesses will occur. 
Field studies on autogenous bacterin therapy against S. aureus in cattle (Hoedemaker et al., 2001) and S. 
pseudintermedius (Bannoehr et al., 2007) in dogs (Curtis et al., 2006) have followed up patients for more 
than 2 mo. Furthermore, field vaccination trials include much larger animal groups compared to our study. 
The use of larger groups could minimise possible individual effects of the administered autovaccine on 
the animal. If some of the rabbits had to be euthanised before the end of the experiment, there would still 
be a large group of animals left to follow over time. However, the purpose of this study was to test the 
autovaccine in the previously developed skin infection model with a sample size allowing the detection 
of statistically significant differences at a P level of 0.05 between groups A and B.
In this experiment, animals were vaccinated twice with a 2 wk interval and challenged 2 wk after the 
second injection. By adapting the vaccination schedule or applying a longer interval between vaccination 
and infection, the effect of the administered autovaccine could possibly be enhanced. A positive effect 
of vaccination against bovine S. aureus was seen in some studies using vaccination schedules differing 
from the schedule used in this study. In a rabbit model where the efficacy of several bovine S. aureus 
vaccines was evaluated, the immunisation schedule consisted of 3 subsequent injections with a 10 d 
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interval with a vaccine composed of somatic cell antigens and toxoid. After the challenge, which was 
performed 3 mo after immunisation, the lesions were significantly less severe than in the non-vaccinated 
controls. Depending on the virulence of the challenge strain, this immunisation still had an effect in some 
animals 6 mo after vaccination (Cameron et al., 1979). In a therapeutic vaccination trial of staphylococcal 
conjunctivitis in rabbits, Hinton (1977) noted a clinical improvement when using several eight week 
courses with weekly subcutaneous bacterin administration. Only a temporary improvement was achieved, 
however. 
In the study presented here, the vaccine consisted only of washed formalin-killed bacteria. The addition 
of the culture supernatant, containing staphylococcal enzymes and toxins might enhance the efficacy 
of the vaccine. Several studies on vaccine development for the prevention of bovine staphylococcal 
mastitis focus on the use of vaccines containing inactivated S. aureus supplemented with toxoid, capsule 
or capsular antigens. Those supplements to the bacterin are considered to enhance its efficacy. A vaccine 
consisting of inactivated, highly encapsulated S. aureus cells, inactivated unencapsulated S. aureus and 
crude extract of S. aureus exopolysaccharides was tested in heifers and dairy cows in field trials (Calzolari 
et al., 1997; Giraudo et al., 1997). This vaccine was able to reduce intramammary infection rates but 
did not offer full protection. A study performed on subclinical mastitis in lactating cows, testing the 
effectiveness of an autogenous bacterin with added crude toxoid components, revealed similar findings 
(Hwang et al., 2000). 
No adjuvant was used in this trial. Although previous experiments showed no difference in the degree of 
protection provided by vaccines with or without adjuvants (Cameron et al., 1979), the use of an appropriate 
adjuvant, suitable for rabbits, might enhance the effect of autovaccine administration. 
In conclusion, a positive effect of the administered autogenous bacterin on the maximum abscess diameter 
have been observed. The use of an autovaccine in the present study was however not able to prevent 
abscess formation in rabbits infected with high doses of S. aureus bacteria. To fully investigate the effect 
of the use of an autovaccine, further studies with an emphasis on adapting the vaccination schedule or 
modifying the vaccine by adding S. aureus culture supernatant or a suitable adjuvant need to be carried 
out.
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